Quality of life of patients more than 1 year after surgery for thyroid cancer

Abstract

Purpose

Patients with thyroid cancer are often assumed to have no quality of life (QOL) impairments after treatment because of thyroid cancer’s good prognosis. However, the QOL implications of surgical complications and the necessity to take lifelong medication are seldom assessed.

Methods

Patients who had surgery due to thyroid cancer at the University Medical Center Mainz between 2010 and 2015 and who had calcium or parathyroid hormone levels below the reference values immediately following surgery were eligible for this study. QOL was assessed using the EORTC QLQ-C30 and the thyroid cancer module EORTC QLQ-THY34. Multiple logistic regression was used to determine factors associated with a worse QOL compared with a general population.

Results

A total of 75 (56%) of 134 eligible patients participated in the study. Patients with persistent/prolonged calcium or vitamin D intake reported worse QOL in the domains of global health, physical functioning, role functioning, emotional functioning, and insomnia than patients without current intake. Current calcium and vitamin D intake, higher education, living with a partner, and age had an effect on the odds of having worse QOL than the age- and sex-adjusted general population.

Conclusion

Prolonged calcium and/or vitamin D intake are negatively associated with certain domains of QOL in thyroid cancer patients who are at least 1 year post surgery. Assessment of calcium and vitamin D and diagnosis of hypoparathyroidism are therefore important for the follow-up of thyroid cancer survivors since it may affect their QOL.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374–1403

    CAS  PubMed  Article  Google Scholar 

  2. 2.

    Brown RL, de Souza JA, Cohen EE (2011) Thyroid cancer: burden of illness and management of disease. J Cancer 2:193–199

    PubMed  PubMed Central  Article  Google Scholar 

  3. 3.

    Wu LM, Gu HY, Qu XH, Zheng J, Zhang W, Yin Y et al (2012) The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: a meta-analysis. Eur J Radiol 81(8):1798–1805

    PubMed  Article  Google Scholar 

  4. 4.

    Pacini F, Castagna MG, Cipri C, Schlumberger M (2010) Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol) 22(6):475–485

    CAS  Article  Google Scholar 

  5. 5.

    Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S et al (2009) The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One 4(1):e4191

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  6. 6.

    Gamper EM, Wintner LM, Rodrigues M, Buxbaum S, Nilica B, Singer S et al (2015) Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme. Eur J Nucl Med Mol Imaging 42(8):1179–1188

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Singer S, Lincke T, Gamper E, Bhaskaran K, Schreiber S, Hinz A et al (2012) Quality of life in patients with thyroid cancer compared with the general population. Thyroid. 22(2):117–124

    PubMed  Article  Google Scholar 

  8. 8.

    Husson O, Haak HR, Oranje WA, Mols F, Reemst PH, van de Poll-Franse LV (2011) Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endocrinol 75(4):544–554

    Article  Google Scholar 

  9. 9.

    Husson O, Haak HR, Buffart LM, Nieuwlaat WA, Oranje WA, Mols F et al (2013) Health-related quality of life and disease specific symptoms in long-term thyroid cancer survivors: a study from the population-based PROFILES registry. Acta Oncol 52(2):249–258

    PubMed  Article  Google Scholar 

  10. 10.

    Hedman C, Djarv T, Strang P, Lundgren CI (2016) Determinants of long-term quality of life in patients with differentiated thyroid carcinoma—a population-based cohort study in Sweden. Acta Oncol 55(3):365–369

    PubMed  Article  Google Scholar 

  11. 11.

    Hoftijzer HC, Heemstra KA, Corssmit EP, van der Klaauw AA, Romijn JA, Smit JW (2008) Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93(1):200–203

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Bergenfelz A, Jansson S, Kristoffersson A, Martensson H, Reihner E, Wallin G et al (2008) Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbeck's Arch Surg 393(5):667–673

    CAS  Article  Google Scholar 

  13. 13.

    Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H (2003) The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery. 133(2):180–185

    PubMed  Article  Google Scholar 

  14. 14.

    Chadwick DR (2017) Hypocalcaemia and permanent hypoparathyroidism after total/bilateral thyroidectomy in the BAETS registry. Gland Surg 6(Suppl 1):S69–S74

    PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W et al (2015) European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173(2):G1–G20

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Brandi ML, Bilezikian JP, Shoback D, Bouillon R, Clarke BL, Thakker RV et al (2016) Management of Hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab 101(6):2273–2283

    CAS  PubMed  Article  Google Scholar 

  17. 17.

    Marcucci G, Della Pepa G, Brandi ML (2016) Natpara for the treatment of hypoparathyroidism. Expert Opin Biol Ther 16(11):1417–1424

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D et al (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26(10):2317–2337

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. 19.

    Shoback D (2008) Clinical practice. Hypoparathyroidism. N Engl J Med 359(4):391–403

    CAS  PubMed  Article  Google Scholar 

  20. 20.

    Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28(11):2277–2285

    PubMed  Article  Google Scholar 

  21. 21.

    Almquist M, Ivarsson K, Nordenstrom E, Bergenfelz A (2018) Mortality in patients with permanent hypoparathyroidism after total thyroidectomy. Br J Surg 105(10):1313–1318

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Buttner M, Musholt TJ, Singer S (2017) Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine. 58(1):14–20

    PubMed  Article  CAS  Google Scholar 

  23. 23.

    Singer S, Husson O, Tomaszewska IM, Locati LD, Kiyota N, Scheidemann-Wesp U et al (2016) Quality-of-life priorities in patients with thyroid cancer: a multinational European Organisation for Research and Treatment of Cancer phase I study. Thyroid 26(11):1605–1613 (2016)

    PubMed  Article  Google Scholar 

  24. 24.

    Singer S, Jordan S, Locati LD, Pinto M, Tomaszewska IM, Araujo C et al (2017) The EORTC module for quality of life in patients with thyroid cancer: phase III. Endocr Relat Cancer 24(4):197–207

    PubMed  Article  Google Scholar 

  25. 25.

    Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the EORTC Quality of Life Group (2001) The EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treamtent of Cancer, Brussels

    Google Scholar 

  26. 26.

    Schwarz R, Hinz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37(11):1345–1351

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    https://www.r-project.org/foundation/ (last access: 13.07.2019)

  28. 28.

    Banach R, Bartes B, Farnell K, Rimmele H, Shey J, Singer S et al (2013) Results of the Thyroid Cancer Alliance international patient/survivor survey: psychosocial/informational support needs, treatment side effects and international differences in care. Hormones (Athens) 12(3):428–438

    Article  Google Scholar 

  29. 29.

    McIntyre C, Jacques T, Palazzo F, Farnell K, Tolley N (2018) Quality of life in differentiated thyroid cancer. Int J Surg 50:133–136

    PubMed  Article  Google Scholar 

  30. 30.

    Aschebrook-Kilfoy B, James B, Nagar S, Kaplan S, Seng V, Ahsan H et al (2015) Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American Thyroid Cancer Survivorship study. Thyroid. 25(12):1313–1321

    PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Malterling RR, Andersson RE, Falkmer S, Falkmer U, Nilehn E, Jarhult J (2010) Differentiated thyroid cancer in a Swedish county—long-term results and quality of life. Acta Oncol 49(4):454–459

    PubMed  Article  Google Scholar 

  32. 32.

    Pelttari H, Sintonen H, Schalin-Jantti C, Valimaki MJ (2009) Health-related quality of life in long-term follow-up of patients with cured TNM stage I or II differentiated thyroid carcinoma. Clin Endocrinol 70(3):493–497

    Article  Google Scholar 

  33. 33.

    Roberts KJ, Lepore SJ, Urken ML (2008) Quality of life after thyroid cancer: an assessment of patient needs and preferences for information and support. J Cancer Educ 23(3):186–191

    PubMed  Article  Google Scholar 

  34. 34.

    Applewhite MK, James BC, Kaplan SP, Angelos P, Kaplan EL, Grogan RH et al (2016) Quality of life in thyroid cancer is similar to that of other cancers with worse survival. World J Surg 40(3):551–561

    PubMed  Article  Google Scholar 

  35. 35.

    Rogers SN, Mepani V, Jackson S, Lowe D (2017) Health-related quality of life, fear of recurrence, and emotional distress in patients treated for thyroid cancer. Br J Oral Maxillofac Surg 55(7):666–673

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Schultz PN, Stava C, Vassilopoulou-Sellin R (2003) Health profiles and quality of life of 518 survivors of thyroid cancer. Head Neck 25(5):349–356

    PubMed  Article  Google Scholar 

  37. 37.

    Bago AG, Dimitrov E, Saunders R, Seress L, Palkovits M, Usdin TB et al (2009) Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience. 162(1):128–147

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Balabanov S, Tollner U, Richter HP, Pohlandt F, Gaedicke G, Teller WM (1984) Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid. Acta Endocrinol 106(2):227–233

    CAS  PubMed  Article  Google Scholar 

  39. 39.

    Divieti P, Inomata N, Chapin K, Singh R, Juppner H, Bringhurst FR (2001) Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology. 142(2):916–925

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Usdin TB, Bonner TI, Hoare SR (2002) The parathyroid hormone 2 (PTH2) receptor. Receptors Channels 8(3–4):211–218

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Taieb D, Baumstarck-Barrau K, Sebag F, Fortanier C, De Micco C, Loundou A et al (2011) Heath-related quality of life in thyroid cancer patients following radioiodine ablation. Health Qual Life Outcomes 9:33

    PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W et al (2006) Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 15(4):695–703

    PubMed  Article  Google Scholar 

  43. 43.

    James BC, Aschebrook-Kilfoy B, White MG, Applewhite MK, Kaplan SP, Angelos P et al (2018) Quality of life in thyroid cancer-assessment of physician perceptions. J Surg Res 226:94–99

    PubMed  Article  Google Scholar 

Download references

Funding

This study was funded by the MAIFOR program of the Johannes Gutenberg-University Mainz, Germany.

Author information

Affiliations

Authors

Contributions

All authors contributed to the conception and design of the study. All authors participated in drafting or critically revising the manuscript, and all authors’ approved the final version of the manuscript for submission.

Matthias Büttner and Thomas Musholt contributed to the acquisition and interpretation of data.

Matthias Büttner contributed to the analysis of the data.

Matthias Büttner will use this paper for his PhD thesis.

Corresponding author

Correspondence to Matthias Büttner.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures involving human participants in this study were performed in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

This study was approved by the Ethics-Committee of the Landesärztekammer Rhineland-Palatinate (# 837.238.16).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Büttner, M., Hinz, A., Singer, S. et al. Quality of life of patients more than 1 year after surgery for thyroid cancer. Hormones 19, 233–243 (2020). https://doi.org/10.1007/s42000-020-00186-x

Download citation

Keywords

  • Quality of life
  • Thyroid cancer
  • Calcium
  • Vitamin D